[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100365984":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":25,"responsibleParty":40,"collaborators":42,"id":45,"slug":7,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":7,"eligibilityCriteria":49,"healthyVolunteers":46,"sex":50,"minAge":51,"maxAge":7,"enrollmentInfo":52,"targetDuration":7,"studyType":55,"phases":7,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Sample collection","Plasma and BAL sample collection",[13],{"name":14,"affiliation":15,"role":16},"Isabel Spriet, PharmD, PhD","UZ Leuven","PRINCIPAL_INVESTIGATOR",[18,22],{"name":14,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","+32 16 34 30 80","isabel.spriet@uzleuven.be",{"name":23,"role":19,"phone":20,"phoneExt":7,"email":24},"Ruth Van Daele, PharmD","ruth.vandaele@uzleuven.be",[26],{"facility":15,"status":27,"city":28,"state":7,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Leuven","3000","Belgium",{"type":32,"coordinates":33},"Point",[34,35],4.70093,50.87959,{"lat":35,"lon":34},[38,39],{"name":14,"role":19,"phone":20,"phoneExt":7,"email":21},{"name":23,"role":19,"phone":20,"phoneExt":7,"email":24},{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[43],{"name":44,"class":6},"KU Leuven","100365984",false,"NCT04045366","Impact of Capillary Leak and Hypoalbuminemia on PK\u002FPD of Anidulafungin and Caspofungin in Critically Ill Patients","Inclusion Criteria:\n\n* Treatment with anidulafungin or caspofungin\n* Admitted to an ICU ward\n\nExclusion Criteria:\n\n* \\\u003C 18 years\n* DNR 2 or 3","ALL","18 Years",{"count":53,"type":54},60,"ESTIMATED","OBSERVATIONAL","This prospective study will explore the pharmacokinetic exposure and pharmacodynamics of the echinocandins (caspofungin or anidulafungin) in critically ill patients.",[58],"Critically Ill Patients",[60,61,62],"Pharmacokinetics","Echinocandins","Critically ill patients","2024-07-02",{"date":65,"type":66},"2024-07-03","ACTUAL",{"date":68,"type":66},"2012-09-21",{"date":70,"type":54},"2025-12-31",{"name":5,"class":6},1]